1. Diabetes Drug Reduces Heart Failure Risk in Cancer Patients by 50% – A Game-Changer for Recovery
A widely used diabetes medication, SGLT2 inhibitors, has shown a surprising benefit for cancer patients—protecting their hearts from chemotherapy-related damage. Researchers found that it slashes heart failure risk and hospitalizations…